Articles On Telix Pharmaceuticals (ASX:TLX)

Australian shares saw modest declines despite gains in energy stocks, with the overall index experiencing a slight downturn. Meanwhile, the S&P 500 reached another record high, boosted by Nvidia's substantial 3.5% increase, which propel...

At 11:30am, the S&P/ASX 200 is 0.92 per cent higher at 7,771.10, mirroring a continued surge in New York where Tesla and Apple led gains in the blue-chip technology sector. This trend reflects positive investor sentiment and strength in...

Australian shares fell on Monday, with the benchmark S&P/ASX 200 closing 0.3% lower, led by declines in energy and mining sectors due to disappointing Chinese economic data and cautious sentiment ahead of the Reserve Bank’s rate decisio...

Australian job advertisements, as measured by ANZ-Indeed, decreased by 2.1% in May, following a peak decline of 23.9% from November 2022, yet remaining over 20% higher than pre-pandemic levels. At 11:30am, the S&P/ASX 200 is 0.06 per ce...

ASX200 dropped on Friday, extending its weekly loss despite Wall Street’s highs Telix Pharma halted US IPO; Tabcorp jumps 10pc on NSW tax reform Germany works to soften EU tariffs on Chinese electric cars   The ASX200 dropped by -0.3% on...

Telix Pharmaceuticals (ASX: TLX), one of the nation’s largest biotechnology companies, has announced today it has withdrawn plans to raise USD$200 million (AUD$300 million) and list on the Nasdaq after finding the proposed discounted prices...

ASX health stocks fall in past five days in line with broader markets on mixed economic signals The ACCC raises concerns about proposed merger of Sigma Healthcare and unlisted Chemist Warehouse Radiopharmaceuticals-focused Telix Pharmaceut...

The ASX200 is trading down around 0.3%. The discretionary sector has made gains of 0.3%, all other sectors have fallen, Industrials has been hit the most down nearly a per cent. The Bank of Japan will make its interest rate decision a...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down after shelving its plan to list in the US. Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals...

International growth plans for Telix Pharmaceuticals (ASX:TLX) – proudly boasting its intentions to list on the NASDAQ for a while now – have come to an anticlimactic end. The company has confirmed on Friday that despite “incredibly long...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a fall today. Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed on Tuesday trading for $16.46. Shares were frozen yesterday after the stock...

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. Tesla (NASDAQ: TSLA) stock gained in Thursday's daily trading session, with the electric vehicle (EV) innovator's share price up a...

Although Telix Pharmaceuticals Ltd (ASX: TLX) shares have been on fire over the last 12 months, they have recently pulled back. For example, since peaking at a record high of $19.06 earlier this month, the radiopharmaceuticals company's sha...

ASX rises +0.5pc driven by tech, banking, and property sectors This comes as US Fed maintains rates, now plans only one cut in 2024 Aussie unemployment drops to 4pc in May, but analysts predict further rises   Aussie shares rose by +0.5%...

Up 63% so far in 2024, the Telix Pharmaceuticals Ltd (ASX: TLX) share price isn't going anywhere today. Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed yesterday trading for $16.46 apiece. Which is where the...

Looking for some top S&P/ASX 200 Index (ASX: XJO) stocks to tap into the massive growth potential presented by the rapid rise of artificial intelligence (AI)? Read on! With an eye on that growth potential, shares in generative AI chip...

At 11:30am, the S&P/ASX 200 is 1.27 per cent lower at 7,760.30, mirroring losses in Europe due to better-than-expected performance by far-right parties in weekend elections, and in anticipation of the US Federal Reserve's resistance to...

The performance of the healthcare sector has been relatively underwhelming in recent times. While this is disappointing, the team at Wilsons believes that things could change in the near future. This could make it a great time for investors...

Looking to invest in an ASX biotech share with the potential to become the next Telix Pharmaceuticals Ltd (ASX: TLX)? You're not alone! The S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company has been going from strength to st...

Australian shares opened with a 0.2% increase driven by gains in mining sectors like iron ore, lithium, and coal, although this was tempered by weaknesses in healthcare and technology. Key mining players such as Fortescue and BHP experience...

ASX investors woke today to news that the European Central Bank had cut interest rates. In a broadly expected move, the ECB lowered the official interest rate by 0.25%, taking it from 4.00% to 3.75%. This marks the first easing by the ECB s...

Given June is upon us, so too is tax time… along with the moons and Ferris wheels. It's natural for Australians to be thinking about any dollars they can save when they lodge their next tax return at this time of year. To indulge this admir...

S&P/ASX 200 Index (ASX: XJO) investors hoping for interest rate relief from the Reserve Bank of Australia are eyeing the overnight announcement from the Bank of Canada. In a move that was widely expected, the Bank of Canada cut the nat...

The European Lithium Ltd (ASX: EUR) share price has been a strong performer on Thursday. At the time of writing, the ASX lithium stock is up 12% to 5.6 cents. This is despite many of its peers, such as Core Lithium Ltd (ASX: CXO), tumbling...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has caught the eye of investors on Thursday. In morning trade, the radiopharmaceuticals company's shares surged over 6% to a record high of $19.06. Telix's shares have since pulled back b...

By Rudi Filapek-Vandyck, EditorSo far this year, ResMed ((RMD)) shares are down -4.4%, with Cochlear ((COH)) shares down -0.8% and CSL ((CSL)) scraping into positive territory to the tune of 1.2%Doesn't sound like much? Always good to know...

Morgan Stanley and Jefferies are among the managers overseeing Telix Pharma’s (ASX:TLX) freshly commenced US IPO process to raise $300M and list on the NASDAQ. First announced in mid-late May, Telix will offer American Depositary Shares...

The Australian market is tipped to open higher this morning, with futures up 52.3 points at 8:49 AEST, mainly riding on a rally in the United States which saw the S&P 500 and Nasdaq bourses close at record highs. On Wednesday in the...

By Tim Boreham, Editor, The New Criterion ASX code: ((ATX)) Market cap: $17.93m Shares on issue: 271,609,233 Chief executive officer: Dr Chris Burns (co-founder) Board: Dr Warwick Tong (chair), Dr Burns, Dr Robert Peach, Jane Bell Financial...

Overseas markets rallied in May on lower bond yields and stabilising inflation prints, but the Australian market couldn't sustain the early May up-swing, weighed down by a surprisingly high April CPI reading and some negative earnings updat...

Wealth Within analyst Filip Tortevski has been eyeing some big gun miners whose stock has been falling for a while now, contemplating the historic value of blue chips which tend to rebound spectacularly when the market improves. None of...

Aus shares began the session with minimal change, leveling off shortly after the market opened. This stagnation was attributed to a decline in commodity prices, which adversely affected mining firms, counterbalancing any positive momentum i...

The big news in shares vs. property is Brisbane overtaking Canberra as Australia's second-most expensive city, with the median home value in the Sunshine State's capital rising 1.4% last month. The last time Brisbane was the second high...

Three S&P/ASX 200 Index (ASX: XJO) stocks did more than their fair share of the heavy lifting in May. The month just past saw the ASX 200 close up 0.5% at 7,701.7 points. But these three companies left those gains far behind. Which com...

INOVIQ’s exosomes therapy to target breast cancer cells INOVIQ (ASX:IIQ) said it has created specialised exosomes (EEVs) designed to target and destroy breast cancer cells in a lab setting. Using a special protein called a chimeric antigen...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has bounced back into the green today. Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed up 15.3% on Friday trading for $18.15 apiece. At the time of wri...

What grabbed the headlines last week?   Major global share markets fell over the last week, as higher bond yields weighed. We also learned that, in America, a convicted felon can totally run for president. The current pres might need to pi...

The S&P/ASX 200 Index (ASX: XJO) had a relatively decent time in May. During the month, the benchmark index rose by 0.5% to end the period at 7,701.7 points. While that was positive, a number of ASX 200 shares smashed the market with s...

Melbourne-based Telix Pharmaceuticals Ltd (ASX:TLX) has reported that data from recent tests on TLX591 – therapy targeted at treatment of specific forms of prostate cancer – reveal that people can live with the disease without it getting wo...

The ASX200 is trading up around 0.55% With strong performances from major medical companies, the healthcare sector is leading gains, up 1.2%, Discretionary follows, up nearly a per cent. IT is the only sector to fall into the red, dow...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At the time of writing, the benchmark index is up 0.55% to 7,670 points. Four ASX shares that are rising more than most today are li...

FDA approves AVITA’s RECELL GO System Wound care medical company, AVITA Medical ASX:AVH), surged +13% this morning after receiving an FDA approval for its latest product, the RECELL GO System. The RECELL GO system basically harvests a small...

31 May 2024 - A snapshot of the stocks on the move, featuring Telix Pharmaceuticals (ASX:TLX), AVITA Medical (ASX:AVH) and EZZ Life Science (ASX:EZZ).

At 11:30am, the S&P/ASX 200 is 0.49 per cent higher at 7,665.70, following a three-day sell-off, driven by broad buying spurred by slightly elevated April inflation data. Meanwhile, in New York, tech stocks declined as US consumer spend...

  To register for today's webinar click here. Telix Pharmaceuticals (ASX:TLX) announces additional positive data from the ProstACT SELECT trial of TLX591. TLX591 is an investigational anti-PSMA1 radio-antibody-drug conjugate (rADC) therapy...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed yesterday at $15.74. At the time of writing, shares are trading 10.6% higher at...

The ASX200 is set to rise by +0.80% on Friday following a lacklustre week for the bourse. The USA’s latest GDP growth data for Q1 came in overnight cooler than expected. The United States logged growth of 1.3% in the first three mont...

ASX biotech shares have been showing significant signs of momentum lately. Exciting clinical trial results and strong investor interest are propelling the sector forward. Plenty of upcoming catalysts and company-specific developments could...

In this week’s video insight, I discuss the remarkable progress of Telix Pharmaceuticals (ASX:TLX). Over the past ten months, Telix’s share price has seen significant growth, driven by advancements in radiation imaging and therapy technolog...

In this week’s video insight, I discuss the remarkable progress of Telix Pharmaceuticals (ASX:TLX). Over the past ten months, Telix’s share price has seen significant growth, driven by advancements in radiation imaging and therapy technolog...